..., IA and IV + IA thrombolysis is associated with an increased sICH risk as compared to IV thrombolysis, and this risk is independent of differences in baseline parameters such as age, initial NIHSS score or pretreatment lesion size. 19 05 2008 25 11 2008 16 2 2009 Stroke, acute...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Stroke, acute Cognitive disorders, prevalence Cognitive disorders, clinical determinants Neuropsychological disorders are common manifestations in the early phase...

... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Stroke, acute Stroke management, quality...

..., or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Stroke...

... data. Electrocardiography, QT prolongation Stroke, acute Coronary heart disease QT prolongation Table 5 shows the frequencies of potentially QT-prolonging factors and their relation to insular involvement and QT prolongation. The association of QT prolongation with one or more...

... in 1998. Because Australia is sparsely populated, 21% of Australians live in remote areas and are unable to receive tPA or neuroprotectant therapy [ 14 ]. Stroke, acute Tissue plasminogen activator Community-based stroke units With the introduction of any new intervention in medicine...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Brain infarction Transient ischemic attack Stroke, acute Stroke management Stroke is the third leading cause of death and a major cause of long-term disability in Japan. Stroke mortality has...

... and for improvement of patient outcome, in particular, in the future after approval of intravenous recombinant tissue plasminogen activator for acute ischemic stroke by the Japanese government. Brain infarction Transient ischemic attack Prospective study Stroke, acute Stroke management © 2004 S. Karger AG...

..., instructions or products referred to in the content or advertisements. Microalbuminuria Stroke, acute Stroke, prognosis Microalbuminuria (MA) is defined as a slight increase above normal in urinary albumin excretion (UAE), ranging from 30 to 300 mg per 24 h [ 1 ]. MA is found in 2.2–10.2...

.... Diffusion-weighted imaging Magnetic resonance imaging Perfusion-weighted imaging Penumbra Stroke, acute Combined diffusion- and perfusion-weighted MRI (DWI and PWI) has recently become a strong diagnostic tool in the early assessment of cerebral ischemia in animals as well as humans [ 1, 2, 3...

..., Thiel A, von Stockhausen HM, Rudolf J: Ischemic brain tissue salvaged from infarction with alteplase. Lancet 1997;349:1599–1600. Thrombolysis Middle cerebral artery occlusion Stroke, acute The efficacy of thrombolysis in patients with acute ischemic stroke has been proven in recent...

..., instructions or products referred to in the content or advertisements. Cardioembolic stroke Recurrent embolization Stroke, acute Stroke, outcome Predictive factors of early recurrent brain or systemic embolization in patients with acute cardioembolic stroke have been assessed in a small number...